 | • レポートコード：GIR-2104Z14120 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、口唇ヘルペス治療・予防のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。口唇ヘルペス治療・予防の種類別市場規模（バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他）、用途別市場規模（外用、経口、注射）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・口唇ヘルペス治療・予防の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GSK、Novartis、Teva、Mylan、Cadila、Apotex、Daewoong Pharmaceutical、Livzon、Luoxin、Med shine、Bayer (Campho Phenique)、Blistex、Kelun Group、Hikma、Haiwang、Carmex、Cipher ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他 ・用途別分析2016年-2026年：外用、経口、注射 ・口唇ヘルペス治療・予防の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・口唇ヘルペス治療・予防のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・口唇ヘルペス治療・予防のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・口唇ヘルペス治療・予防の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・口唇ヘルペス治療・予防の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Treatment and Prevention of Herpes Labialis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Treatment and Prevention of Herpes Labialis size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Treatment and Prevention of Herpes Labialis market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Treatment and Prevention of Herpes Labialis market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Valacyclovir
Aciclovir
Famciclovir
Docosanol
Other
Market segment by Application, can be divided into
External Use
Oral
Injection
Market segment by players, this report covers
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun Group
Hikma
Haiwang
Carmex
Cipher
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Treatment and Prevention of Herpes Labialis
1.2 Classification of Treatment and Prevention of Herpes Labialis by Type
1.2.1 Overview: Global Treatment and Prevention of Herpes Labialis Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type in 2020
1.2.3 Valacyclovir
1.2.4 Aciclovir
1.2.5 Famciclovir
1.2.6 Docosanol
1.2.7 Other
1.3 Global Treatment and Prevention of Herpes Labialis Market by Application
1.3.1 Overview: Global Treatment and Prevention of Herpes Labialis Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Global Treatment and Prevention of Herpes Labialis Market Size & Forecast
1.5 Global Treatment and Prevention of Herpes Labialis Market Size and Forecast by Region
1.5.1 Global Treatment and Prevention of Herpes Labialis Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Treatment and Prevention of Herpes Labialis Market Size by Region, (2016-2021)
1.5.3 North America Treatment and Prevention of Herpes Labialis Market Size and Prospect (2016-2026)
1.5.4 Europe Treatment and Prevention of Herpes Labialis Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size and Prospect (2016-2026)
1.5.6 South America Treatment and Prevention of Herpes Labialis Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Treatment and Prevention of Herpes Labialis Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Treatment and Prevention of Herpes Labialis Market Drivers
1.6.2 Treatment and Prevention of Herpes Labialis Market Restraints
1.6.3 Treatment and Prevention of Herpes Labialis Trends Analysis
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Treatment and Prevention of Herpes Labialis Product and Solutions
2.1.4 GSK Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GSK Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Treatment and Prevention of Herpes Labialis Product and Solutions
2.2.4 Novartis Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Treatment and Prevention of Herpes Labialis Product and Solutions
2.3.4 Teva Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Teva Recent Developments and Future Plans
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Treatment and Prevention of Herpes Labialis Product and Solutions
2.4.4 Mylan Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Mylan Recent Developments and Future Plans
2.5 Cadila
2.5.1 Cadila Details
2.5.2 Cadila Major Business
2.5.3 Cadila Treatment and Prevention of Herpes Labialis Product and Solutions
2.5.4 Cadila Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Cadila Recent Developments and Future Plans
2.6 Apotex
2.6.1 Apotex Details
2.6.2 Apotex Major Business
2.6.3 Apotex Treatment and Prevention of Herpes Labialis Product and Solutions
2.6.4 Apotex Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Apotex Recent Developments and Future Plans
2.7 Daewoong Pharmaceutical
2.7.1 Daewoong Pharmaceutical Details
2.7.2 Daewoong Pharmaceutical Major Business
2.7.3 Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Product and Solutions
2.7.4 Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Daewoong Pharmaceutical Recent Developments and Future Plans
2.8 Livzon
2.8.1 Livzon Details
2.8.2 Livzon Major Business
2.8.3 Livzon Treatment and Prevention of Herpes Labialis Product and Solutions
2.8.4 Livzon Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Livzon Recent Developments and Future Plans
2.9 Luoxin
2.9.1 Luoxin Details
2.9.2 Luoxin Major Business
2.9.3 Luoxin Treatment and Prevention of Herpes Labialis Product and Solutions
2.9.4 Luoxin Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Luoxin Recent Developments and Future Plans
2.10 Med shine
2.10.1 Med shine Details
2.10.2 Med shine Major Business
2.10.3 Med shine Treatment and Prevention of Herpes Labialis Product and Solutions
2.10.4 Med shine Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Med shine Recent Developments and Future Plans
2.11 Bayer (Campho Phenique)
2.11.1 Bayer (Campho Phenique) Details
2.11.2 Bayer (Campho Phenique) Major Business
2.11.3 Bayer (Campho Phenique) Treatment and Prevention of Herpes Labialis Product and Solutions
2.11.4 Bayer (Campho Phenique) Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Bayer (Campho Phenique) Recent Developments and Future Plans
2.12 Blistex
2.12.1 Blistex Details
2.12.2 Blistex Major Business
2.12.3 Blistex Treatment and Prevention of Herpes Labialis Product and Solutions
2.12.4 Blistex Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Blistex Recent Developments and Future Plans
2.13 Kelun Group
2.13.1 Kelun Group Details
2.13.2 Kelun Group Major Business
2.13.3 Kelun Group Treatment and Prevention of Herpes Labialis Product and Solutions
2.13.4 Kelun Group Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Kelun Group Recent Developments and Future Plans
2.14 Hikma
2.14.1 Hikma Details
2.14.2 Hikma Major Business
2.14.3 Hikma Treatment and Prevention of Herpes Labialis Product and Solutions
2.14.4 Hikma Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Hikma Recent Developments and Future Plans
2.15 Haiwang
2.15.1 Haiwang Details
2.15.2 Haiwang Major Business
2.15.3 Haiwang Treatment and Prevention of Herpes Labialis Product and Solutions
2.15.4 Haiwang Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Haiwang Recent Developments and Future Plans
2.16 Carmex
2.16.1 Carmex Details
2.16.2 Carmex Major Business
2.16.3 Carmex Treatment and Prevention of Herpes Labialis Product and Solutions
2.16.4 Carmex Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Carmex Recent Developments and Future Plans
2.17 Cipher
2.17.1 Cipher Details
2.17.2 Cipher Major Business
2.17.3 Cipher Treatment and Prevention of Herpes Labialis Product and Solutions
2.17.4 Cipher Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Cipher Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Treatment and Prevention of Herpes Labialis Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Treatment and Prevention of Herpes Labialis Players Market Share
3.2.2 Top 10 Treatment and Prevention of Herpes Labialis Players Market Share
3.2.3 Market Competition Trend
3.3 Treatment and Prevention of Herpes Labialis Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Treatment and Prevention of Herpes Labialis Revenue and Market Share by Type (2016-2021)
4.2 Global Treatment and Prevention of Herpes Labialis Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2016-2021)
5.2 Treatment and Prevention of Herpes Labialis Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Treatment and Prevention of Herpes Labialis Revenue by Type (2016-2026)
6.2 North America Treatment and Prevention of Herpes Labialis Revenue by Application (2016-2026)
6.3 North America Treatment and Prevention of Herpes Labialis Market Size by Country
6.3.1 North America Treatment and Prevention of Herpes Labialis Revenue by Country (2016-2026)
6.3.2 United States Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
6.3.3 Canada Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
6.3.4 Mexico Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Treatment and Prevention of Herpes Labialis Revenue by Type (2016-2026)
7.2 Europe Treatment and Prevention of Herpes Labialis Revenue by Application (2016-2026)
7.3 Europe Treatment and Prevention of Herpes Labialis Market Size by Country
7.3.1 Europe Treatment and Prevention of Herpes Labialis Revenue by Country (2016-2026)
7.3.2 Germany Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
7.3.3 France Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
7.3.5 Russia Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
7.3.6 Italy Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Type (2016-2026)
8.2 Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Application (2016-2026)
8.3 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region
8.3.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Region (2016-2026)
8.3.2 China Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
8.3.3 Japan Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
8.3.4 South Korea Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
8.3.5 India Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
8.3.7 Australia Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Treatment and Prevention of Herpes Labialis Revenue by Type (2016-2026)
9.2 South America Treatment and Prevention of Herpes Labialis Revenue by Application (2016-2026)
9.3 South America Treatment and Prevention of Herpes Labialis Market Size by Country
9.3.1 South America Treatment and Prevention of Herpes Labialis Revenue by Country (2016-2026)
9.3.2 Brazil Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
9.3.3 Argentina Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Type (2016-2026)
10.2 Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Application (2016-2026)
10.3 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country
10.3.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Country (2016-2026)
10.3.2 Turkey Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
10.3.4 UAE Treatment and Prevention of Herpes Labialis Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Treatment and Prevention of Herpes Labialis Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Treatment and Prevention of Herpes Labialis Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Treatment and Prevention of Herpes Labialis Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Treatment and Prevention of Herpes Labialis Revenue (USD Million) by Region (2016-2021)
Table 5. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Region (2021-2026)
Table 6. GSK Corporate Information, Head Office, and Major Competitors
Table 7. GSK Major Business
Table 8. GSK Treatment and Prevention of Herpes Labialis Product and Solutions
Table 9. GSK Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Treatment and Prevention of Herpes Labialis Product and Solutions
Table 13. Novartis Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Teva Corporate Information, Head Office, and Major Competitors
Table 15. Teva Major Business
Table 16. Teva Treatment and Prevention of Herpes Labialis Product and Solutions
Table 17. Teva Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Mylan Corporate Information, Head Office, and Major Competitors
Table 19. Mylan Major Business
Table 20. Mylan Treatment and Prevention of Herpes Labialis Product and Solutions
Table 21. Mylan Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Cadila Corporate Information, Head Office, and Major Competitors
Table 23. Cadila Major Business
Table 24. Cadila Treatment and Prevention of Herpes Labialis Product and Solutions
Table 25. Cadila Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Apotex Corporate Information, Head Office, and Major Competitors
Table 27. Apotex Major Business
Table 28. Apotex Treatment and Prevention of Herpes Labialis Product and Solutions
Table 29. Apotex Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Daewoong Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 31. Daewoong Pharmaceutical Major Business
Table 32. Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Product and Solutions
Table 33. Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Livzon Corporate Information, Head Office, and Major Competitors
Table 35. Livzon Major Business
Table 36. Livzon Treatment and Prevention of Herpes Labialis Product and Solutions
Table 37. Livzon Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Luoxin Corporate Information, Head Office, and Major Competitors
Table 39. Luoxin Major Business
Table 40. Luoxin Treatment and Prevention of Herpes Labialis Product and Solutions
Table 41. Luoxin Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Med shine Corporate Information, Head Office, and Major Competitors
Table 43. Med shine Major Business
Table 44. Med shine Treatment and Prevention of Herpes Labialis Product and Solutions
Table 45. Med shine Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Bayer (Campho Phenique) Corporate Information, Head Office, and Major Competitors
Table 47. Bayer (Campho Phenique) Major Business
Table 48. Bayer (Campho Phenique) Treatment and Prevention of Herpes Labialis Product and Solutions
Table 49. Bayer (Campho Phenique) Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Blistex Corporate Information, Head Office, and Major Competitors
Table 51. Blistex Major Business
Table 52. Blistex Treatment and Prevention of Herpes Labialis Product and Solutions
Table 53. Blistex Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Kelun Group Corporate Information, Head Office, and Major Competitors
Table 55. Kelun Group Major Business
Table 56. Kelun Group Treatment and Prevention of Herpes Labialis Product and Solutions
Table 57. Kelun Group Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Hikma Corporate Information, Head Office, and Major Competitors
Table 59. Hikma Major Business
Table 60. Hikma Treatment and Prevention of Herpes Labialis Product and Solutions
Table 61. Hikma Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Haiwang Corporate Information, Head Office, and Major Competitors
Table 63. Haiwang Major Business
Table 64. Haiwang Treatment and Prevention of Herpes Labialis Product and Solutions
Table 65. Haiwang Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Carmex Corporate Information, Head Office, and Major Competitors
Table 67. Carmex Major Business
Table 68. Carmex Treatment and Prevention of Herpes Labialis Product and Solutions
Table 69. Carmex Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Cipher Corporate Information, Head Office, and Major Competitors
Table 71. Cipher Major Business
Table 72. Cipher Treatment and Prevention of Herpes Labialis Product and Solutions
Table 73. Cipher Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Global Treatment and Prevention of Herpes Labialis Revenue (USD Million) by Players (2019-2021)
Table 75. Global Treatment and Prevention of Herpes Labialis Revenue Share by Players (2019-2021)
Table 76. Breakdown of Treatment and Prevention of Herpes Labialis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Treatment and Prevention of Herpes Labialis Players Head Office, Products and Services Provided
Table 78. Treatment and Prevention of Herpes Labialis Mergers & Acquisitions in the Past Five Years
Table 79. Treatment and Prevention of Herpes Labialis New Entrants and Expansion Plans
Table 80. Global Treatment and Prevention of Herpes Labialis Revenue (USD Million) by Type (2016-2021)
Table 81. Global Treatment and Prevention of Herpes Labialis Revenue Share by Type (2016-2021)
Table 82. Global Treatment and Prevention of Herpes Labialis Revenue Forecast by Type (2021-2026)
Table 83. Global Treatment and Prevention of Herpes Labialis Revenue by Application (2016-2021)
Table 84. Global Treatment and Prevention of Herpes Labialis Revenue Forecast by Application (2021-2026)
Table 85. North America Treatment and Prevention of Herpes Labialis Revenue by Type (2016-2021) & (USD Million)
Table 86. North America Treatment and Prevention of Herpes Labialis Revenue by Type (2021-2026) & (USD Million)
Table 87. North America Treatment and Prevention of Herpes Labialis Revenue by Application (2016-2021) & (USD Million)
Table 88. North America Treatment and Prevention of Herpes Labialis Revenue by Application (2021-2026) & (USD Million)
Table 89. North America Treatment and Prevention of Herpes Labialis Revenue by Country (2016-2021) & (USD Million)
Table 90. North America Treatment and Prevention of Herpes Labialis Revenue by Country (2021-2026) & (USD Million)
Table 91. Europe Treatment and Prevention of Herpes Labialis Revenue by Type (2016-2021) & (USD Million)
Table 92. Europe Treatment and Prevention of Herpes Labialis Revenue by Type (2021-2026) & (USD Million)
Table 93. Europe Treatment and Prevention of Herpes Labialis Revenue by Application (2016-2021) & (USD Million)
Table 94. Europe Treatment and Prevention of Herpes Labialis Revenue by Application (2021-2026) & (USD Million)
Table 95. Europe Treatment and Prevention of Herpes Labialis Revenue by Country (2016-2021) & (USD Million)
Table 96. Europe Treatment and Prevention of Herpes Labialis Revenue by Country (2021-2026) & (USD Million)
Table 97. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Type (2016-2021) & (USD Million)
Table 98. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Type (2021-2026) & (USD Million)
Table 99. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Application (2016-2021) & (USD Million)
Table 100. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Application (2021-2026) & (USD Million)
Table 101. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Region (2016-2021) & (USD Million)
Table 102. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Region (2021-2026) & (USD Million)
Table 103. South America Treatment and Prevention of Herpes Labialis Revenue by Type (2016-2021) & (USD Million)
Table 104. South America Treatment and Prevention of Herpes Labialis Revenue by Type (2021-2026) & (USD Million)
Table 105. South America Treatment and Prevention of Herpes Labialis Revenue by Application (2016-2021) & (USD Million)
Table 106. South America Treatment and Prevention of Herpes Labialis Revenue by Application (2021-2026) & (USD Million)
Table 107. South America Treatment and Prevention of Herpes Labialis Revenue by Country (2016-2021) & (USD Million)
Table 108. South America Treatment and Prevention of Herpes Labialis Revenue by Country (2021-2026) & (USD Million)
Table 109. Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Type (2016-2021) & (USD Million)
Table 110. Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Type (2021-2026) & (USD Million)
Table 111. Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Application (2016-2021) & (USD Million)
Table 112. Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Application (2021-2026) & (USD Million)
Table 113. Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Country (2016-2021) & (USD Million)
Table 114. Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Treatment and Prevention of Herpes Labialis Picture
Figure 2. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type in 2020
Figure 3. Valacyclovir
Figure 4. Aciclovir
Figure 5. Famciclovir
Figure 6. Docosanol
Figure 7. Other
Figure 8. Treatment and Prevention of Herpes Labialis Revenue Market Share by Application in 2020
Figure 9. External Use Picture
Figure 10. Oral Picture
Figure 11. Injection Picture
Figure 12. Global Treatment and Prevention of Herpes Labialis Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Treatment and Prevention of Herpes Labialis Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Region (2016-2026)
Figure 15. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Region in 2020
Figure 16. North America Treatment and Prevention of Herpes Labialis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Treatment and Prevention of Herpes Labialis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Treatment and Prevention of Herpes Labialis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Treatment and Prevention of Herpes Labialis Market Drivers
Figure 21. Treatment and Prevention of Herpes Labialis Market Restraints
Figure 22. Treatment and Prevention of Herpes Labialis Market Trends
Figure 23. GSK Recent Developments and Future Plans
Figure 24. Novartis Recent Developments and Future Plans
Figure 25. Teva Recent Developments and Future Plans
Figure 26. Mylan Recent Developments and Future Plans
Figure 27. Cadila Recent Developments and Future Plans
Figure 28. Apotex Recent Developments and Future Plans
Figure 29. Daewoong Pharmaceutical Recent Developments and Future Plans
Figure 30. Livzon Recent Developments and Future Plans
Figure 31. Luoxin Recent Developments and Future Plans
Figure 32. Med shine Recent Developments and Future Plans
Figure 33. Bayer (Campho Phenique) Recent Developments and Future Plans
Figure 34. Blistex Recent Developments and Future Plans
Figure 35. Kelun Group Recent Developments and Future Plans
Figure 36. Hikma Recent Developments and Future Plans
Figure 37. Haiwang Recent Developments and Future Plans
Figure 38. Carmex Recent Developments and Future Plans
Figure 39. Cipher Recent Developments and Future Plans
Figure 41. Global Treatment and Prevention of Herpes Labialis Revenue Share by Players in 2020
Figure 42. Treatment and Prevention of Herpes Labialis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 43. Global Top 3 Players Treatment and Prevention of Herpes Labialis Revenue Market Share in 2020
Figure 44. Global Top 10 Players Treatment and Prevention of Herpes Labialis Revenue Market Share in 2020
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 46. Global Treatment and Prevention of Herpes Labialis Revenue Share by Type in 2020
Figure 47. Global Treatment and Prevention of Herpes Labialis Market Share Forecast by Type (2021-2026)
Figure 48. Global Treatment and Prevention of Herpes Labialis Revenue Share by Application in 2020
Figure 49. Global Treatment and Prevention of Herpes Labialis Market Share Forecast by Application (2021-2026)
Figure 50. North America Treatment and Prevention of Herpes Labialis Sales Market Share by Type (2016-2026)
Figure 51. North America Treatment and Prevention of Herpes Labialis Sales Market Share by Application (2016-2026)
Figure 52. North America Treatment and Prevention of Herpes Labialis Revenue Market Share by Country (2016-2026)
Figure 53. United States Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Canada Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Mexico Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Europe Treatment and Prevention of Herpes Labialis Sales Market Share by Type (2016-2026)
Figure 57. Europe Treatment and Prevention of Herpes Labialis Sales Market Share by Application (2016-2026)
Figure 58. Europe Treatment and Prevention of Herpes Labialis Revenue Market Share by Country (2016-2026)
Figure 59. Germany Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. France Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. United Kingdom Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Russia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Italy Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Asia-Pacific Treatment and Prevention of Herpes Labialis Sales Market Share by Type (2016-2026)
Figure 65. Asia-Pacific Treatment and Prevention of Herpes Labialis Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue Market Share by Region (2016-2026)
Figure 67. China Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South Korea Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America Treatment and Prevention of Herpes Labialis Sales Market Share by Type (2016-2026)
Figure 74. South America Treatment and Prevention of Herpes Labialis Sales Market Share by Application (2016-2026)
Figure 75. South America Treatment and Prevention of Herpes Labialis Revenue Market Share by Country (2016-2026)
Figure 76. Brazil Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Argentina Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Middle East and Africa Treatment and Prevention of Herpes Labialis Sales Market Share by Type (2016-2026)
Figure 79. Middle East and Africa Treatment and Prevention of Herpes Labialis Sales Market Share by Application (2016-2026)
Figure 80. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue Market Share by Country (2016-2026)
Figure 81. Turkey Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. UAE Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
世界の口唇ヘルペス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Herpes Labialis Treatment Market The global Herpes Labialis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…- 世界の口唇ヘルペス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Herpes Labialis Treatment Market The global Herpes Labialis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
- 世界の帯状疱疹感染症治療市場規模・現状・予測（2021年-2027年） Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many yea…
- 世界の心房細動（SPAF）治療における脳卒中予防市場規模・現状・予測（2021年-2027年） Atrial fibrillation (AF) now a days has become a common and serious condition affecting almost 1-2% of the total population of age group 65 years and above. Increase in the aging population leads to increase in the prevalence further leads to increase rick of premature death. Market Analysis and Ins…
- 世界の単純ヘルペスウイルス感染症治療市場規模・現状・予測（2021年-2027年） Herpes Simplex Virus Infection is commonly known as herpes. The two types of herpes simplex virus (HSV) are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections is asymptomatic. Symptomatic infections are presented with blis…